India exported 65m
doses of COVID-19 to
100 countries: PM Modi

0
6

NEW DELHI: Laying thrust on developing indigenous capabilities, Prime Minister Narendra Modi on Thursday said that India has exported more than 65 million doses of COVID vaccines to nearly 100 countries this year.

The Prime Minister, who inaugurated the First Global Innovation Summit of the Pharmaceuticals sector via video conferencing, said India believes in the well-being of the entire humankind.

“Our definition of wellness is not limited by physical boundaries. We believe in the well-being of the entire humankind. And, we have shown this spirit to the whole world during the COVID-19 global pandemic,” he said.

“We exported lifesaving medicines and medical equipment to over 150 countries during the initial phase of the pandemic. We have also exported more than 65 million doses of COVID-19 vaccines to nearly 100 countries this year,” he added.

NEW DELHI: Prime Minister Narendra Modi addresses during Global Innovation Summit of Pharmaceuticals sector via video conferencing, in New Delhi on Thursday. (ANI Photo)

The Prime Minister said that India has a large pool of scientists and technologists with a potential to take the industry to greater heights. He added that this strength needs to be harnessed to “Discover and Make in India”.

“Our vision is to create an eco-system for innovation that will make India a leader in drug discovery and innovative medical devices. Our policy interventions are being made based on wide consultation with all stakeholders,” the Prime Minister said.

Global Innovation Summit aims to bring together key Indian and international stakeholders from the government, industry, academia, investors, and researchers to discuss and strategize priorities to foster a thriving innovation ecosystem in the pharmaceuticals industry in India. It will also highlight the opportunities in the Indian pharma industry that has huge growth potential.

The two-day summit will have 12 sessions and over 40 national and international speakers will deliberate on a range of subjects including the regulatory environment, funding for innovation, industry-academia collaboration, and innovation infrastructure.

India being called ‘pharmacy of the world’: Modi

Prime Minister Narendra Modi on Thursday lauded the healthcare sector in the country and said that global trust earned by the Indian healthcare sector has led to India being called the “pharmacy of the world”.

Prime Minister Narendra Modi inaugurated the First Global Innovation Summit of the Pharmaceuticals sector today via video conferencing.

Speaking at the summit, PM Modi said, “Whether it is lifestyle, or medicines, or medical technology, or vaccines, every aspect of healthcare has received global attention over the last two years.”

“In this context, the Indian pharmaceutical industry has also risen to the challenge. The global trust earned by the Indian healthcare sector has led to India being called the ‘pharmacy of the world’ in recent times,” PM said.

NEW DELHI: Prime Minister Narendra Modi addresses during Global Innovation Summit of Pharmaceuticals sector via video conferencing as Union Minister for Health & Family Welfare, Chemicals, and Fertilizers, Mansukh Mandaviya looks on, in New Delhi on Thursday.
(ANI Photo)

The Prime Minister said that India also exported more than 65 million doses of Covid vaccines to nearly 100 countries this year

“Our definition of wellness is not limited by physical boundaries. We believe in the well-being of the entire humankind. And, we have shown this spirit to the whole world during the Covid-19 global pandemic,” he said.

“We exported lifesaving medicines and medical equipment to over 150 countries during the initial phase of the pandemic. We have also exported more than 65 million doses of Covid vaccines to nearly 100 countries this year,” PM Modi added.

The Prime Minister’s office informed that Global Innovation Summit is a distinctive initiative that aims to bring together key Indian and international stakeholders from the government, industry, academia, investors, and researchers to discuss and strategize priorities to foster a thriving innovation ecosystem in the pharmaceuticals industry in India. It will also highlight the opportunities in the Indian pharma industry that has huge growth potential.

The two-day Summit will have 12 Sessions and over 40 national and international speakers deliberating on a range of subjects including the regulatory environment, funding for innovation, industry-academia collaboration, and innovation infrastructure.

It witnesses the participation of leading members from domestic and global Pharma Industries, officials, investors and researchers from Massachusetts Institute of Technology, John Hopkins Institute, IIM Ahmedabad and other eminent institutes.

India reports 11,106 new Covid-19 cases, 459 deaths

India reported 11,106 new COVID-19 cases in the last 24 hours, informed the Ministry of Health and Family Welfare on Friday.
With this, India’s active caseload stands at 1,26,620. The active cases now account for less than 1 per cent of total cases, currently at 0.37 per cent, the lowest since March 2020. With 12,789 people recovering in the last 24 hours, the recovery tally has gone up to 3,38,97,921. The recovery rate is currently at 98.28 per cent, the highest since March 2020.
The country also reported 459 deaths in a day.
As per the health ministry, the daily positivity rate stands at 0.98 per cent. It has remained below 2 per cent for the last 46 days while the weekly positivity rate is at 0.92 per cent, less than 2 per cent for the last 56 days.
India has tested 62.93 crore samples for Covid-19 so far. More than 115.23 crore vaccine doses have been administered under the nationwide vaccination drive. (ANI)